Lataa...
Altered Arsenic Disposition in Experimental Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is represented by a spectrum of liver pathologies ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). Liver damage sustained in the progressive stages of NAFLD may alter the ability of the liver to properly metabolize and eliminate xenobioti...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The American Society for Pharmacology and Experimental Therapeutics
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3422539/ https://ncbi.nlm.nih.gov/pubmed/22699396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.112.046177 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|